Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Multiple Sclerosis

Free Subscription 15.09.2025 1 Ann Neurol 1 Arch Phys Med Rehabil 2 J Neurol 1 J Neurol Neurosurg Psychiatry 4 Mult Scler 1 PLoS Biol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. CERONO G, Cree BAC, Hauser SL, Baranzini SE, et al
   Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence.
   Ann Neurol. 2025 Sep 8. doi: 10.1002/ana.78033.
   PubMed         Abstract available
   
   

   
   Arch Phys Med Rehabil

2. ABASIYANIK Z, Pedulla L, Kahraman T, Soler B, et al
   Prevalence and magnitude of perceived dual-task difficulties in people with multiple sclerosis: an international study.
   Arch Phys Med Rehabil. 2025 Sep 6:S0003-9993(25)00879.
   PubMed         Abstract available
   
   

   
   J Neurol

3. ALONI R, Dror C, Barazani T, Kalron A, et al
   Wartime stress and relapse risk in people with multiple sclerosis: a prospective cohort study.
   J Neurol. 2025;272:619.
   PubMed         Abstract available
   
   
4. YANG J, Li H, Zhang Y, Hu S, et al
   Effects of exercise on fatigue and quality of life in multiple sclerosis: a network meta-analysis and systematic review.
   J Neurol. 2025;272:621.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

5. ELLENBERGER D, Flachenecker P, Haas J, Hellwig K, et al
   Paediatric-onset multiple sclerosis: demographics, symptoms and disease progression.
   J Neurol Neurosurg Psychiatry. 2025 Sep 8:jnnp-2025-336680.
   PubMed         Abstract available
   
   

   
   Mult Scler

6. GERNERT JA, Klein M, Schoberl F, Muller KJ, et al
   Severe course of tick-borne encephalitis (TBE) in a patient with relapsing multiple sclerosis (MS) treated with ocrelizumab.
   Mult Scler. 2025 Sep 11:13524585251369425. doi: 10.1177/13524585251369425.
   PubMed         Abstract available
   
   
7. TOUBASI A, Hett K, Xu J, Gheen C, et al
   Parasagittal dural space and arachnoid granulations morphology in pre-clinical and early clinical multiple sclerosis.
   Mult Scler. 2025 Sep 10:13524585251364720. doi: 10.1177/13524585251364720.
   PubMed         Abstract available
   
   
8. PONZANO M, Fedriga MM, Signori A, Bergamaschi R, et al
   Social determinants of health in multiple sclerosis in Italy: A scoping review.
   Mult Scler. 2025 Sep 10:13524585251353196. doi: 10.1177/13524585251353196.
   PubMed         Abstract available
   
   
9. ZHAO-FLEMING HH, Decker PA, Kosel ML, Drucker KL, et al
   Genomewide association study of a homogeneous multiple sclerosis cohort: Tumefactive demyelination.
   Mult Scler. 2025 Sep 8:13524585251371984. doi: 10.1177/13524585251371984.
   PubMed         Abstract available
   
   

   
   PLoS Biol

10. BELLASSEN L, David K, Lampert B, Sarusi-Portuguez A, et al
    The immune receptor SLAMF5 regulates myeloid-cell mediated neuroinflammation in multiple sclerosis.
    PLoS Biol. 2025;23:e3003373.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.